홈 /
자료 /
컨퍼런스 / Targeted Radiopharmaceuticals Summit
Targeted Radiopharmaceuticals Summit
We are excited to be presenting at this conference!
Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies
Joshua Apgar, PhD
| VP, Global Head of ABM Scientific Affairs
- Learn how clinical pharmacology considerations and model-informed drug development (MIDD) concepts help streamline therapeutic index-focused discovery and drug development for TRTs.
- Learn how to craft strategies that comply with the FDA’s Project Optimus initiative to optimize oncology drug dosage.
- Understand dose optimization requirements for TRT in the clinical pharmacology regulatory landscape.
- Discover how MIDD, including quantitative systems pharmacology (QSP) and pharmacometrics, help drive rational drug design, patient selection, and inform dosage optimization.